Fertility drug timing test aims to boost IVF success

NCT ID NCT06511791

Terminated Disease control Sponsor: Ferring Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage study tested whether giving an experimental fertility drug (FE999302) at different times during an IVF cycle could improve the number of high-quality embryos. It involved about 106 women under 40 with infertility who were undergoing standard IVF treatment. The trial was terminated early, and its main goal was to see if changing the drug's timing affected embryo development.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Ferring Investigational Site

Brussels, 1090, Belgium
Ferring Investigational Site

Edegem, 2650, Belgium
Ferring Investigational Site

Prague, 150 00, Czechia
Ferring Investigational Site

Prague, 16000, Czechia
Ferring Investigational Site

Prague, 184 00, Czechia
Ferring Investigational Site

Copenhagen, 2100, Denmark
Ferring Investigational Site

Hvidovre, 2650, Denmark
Ferring Investigational Site

Bergen, 5006, Norway
Ferring Investigational Site

Porsgrunn, 3913, Norway
Ferring Investigational Site

Trondheim, 7042, Norway
Ferring Investigational Site

Barcelona, 08028, Spain
Ferring Investigational Site

Madrid, 28010, Spain
Ferring Investigational Site

Madrid, 28023, Spain
Ferring Investigational Site

Seville, 41092, Spain
Ferring Investigational Site

Valencia, 46015, Spain

Conditions

Explore the condition pages connected to this study.

INFERTILITY